-
1
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
-
Cholesterol Treatment Trialists' (CTT) Collaborators
-
Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
-
2
-
-
78449281377
-
Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials
-
Cholesterol Treatment Trialists' (CTT) Collaboration
-
Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Lancet 376 2010 1670 1681
-
(2010)
Lancet
, vol.376
, pp. 1670-1681
-
-
-
3
-
-
23944487796
-
Statins and prostate cancer risk: A case-control study
-
J Shannon, S Tewoderos, M Garzotto et al. Statins and prostate cancer risk: a case-control study Am J Epidemiol 162 2005 318 325
-
(2005)
Am J Epidemiol
, vol.162
, pp. 318-325
-
-
Shannon, J.1
Tewoderos, S.2
Garzotto, M.3
-
5
-
-
0026795925
-
Report of the conference on low blood cholesterol: Mortality associations
-
D Jacobs, H Blackburn, M Higgins et al. Report of the conference on low blood cholesterol: mortality associations Circulation 86 1992 1046 1060
-
(1992)
Circulation
, vol.86
, pp. 1046-1060
-
-
Jacobs, D.1
Blackburn, H.2
Higgins, M.3
-
6
-
-
0026681128
-
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
-
JD Neaton, H Blackburn, D Jacobs et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial Arch Intern Med 152 1992 1490 1500
-
(1992)
Arch Intern Med
, vol.152
, pp. 1490-1500
-
-
Neaton, J.D.1
Blackburn, H.2
Jacobs, D.3
-
7
-
-
34447627450
-
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: Insights from large randomized statin trials
-
AA Alsheikh-Ali, PV Maddukuri, H Han, RH Karas Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials J Am Coll Cardiol 50 2007 409 418
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 409-418
-
-
Alsheikh-Ali, A.A.1
Maddukuri, P.V.2
Han, H.3
Karas, R.H.4
-
8
-
-
0025767962
-
Might treatment of hypercholesterolaemia increase non-cardiac mortality?
-
MF Oliver Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet 337 1991 1529 1531
-
(1991)
Lancet
, vol.337
, pp. 1529-1531
-
-
Oliver, M.F.1
-
9
-
-
0026527178
-
Should there be a moratorium on the use of cholesterol lowering drugs?
-
G Davey Smith, J Pekkanen Should there be a moratorium on the use of cholesterol lowering drugs? BMJ 304 1992 431 434
-
(1992)
BMJ
, vol.304
, pp. 431-434
-
-
Davey Smith, G.1
Pekkanen, J.2
-
10
-
-
0030024585
-
Carcinogenicity of lipid-lowering drugs
-
TB Newman, SB Hulley Carcinogenicity of lipid-lowering drugs JAMA 275 1996 55 60
-
(1996)
JAMA
, vol.275
, pp. 55-60
-
-
Newman, T.B.1
Hulley, S.B.2
-
11
-
-
35248901000
-
Long-term follow-up of the West of Scotland Coronary Prevention Study
-
for the West of Scotland Coronary Prevention Study Group
-
I Ford, H Murray, CJ Packard, J Shepherd, PW Macfarlane, SM Cobbe for the West of Scotland Coronary Prevention Study Group Long-term follow-up of the West of Scotland Coronary Prevention Study N Engl J Med 357 2007 1477 1486
-
(2007)
N Engl J Med
, vol.357
, pp. 1477-1486
-
-
Ford, I.1
Murray, H.2
Packard, C.J.3
Shepherd, J.4
MacFarlane, P.W.5
Cobbe, S.M.6
-
12
-
-
80054741504
-
The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK
-
on behalf of the ASCOT Investigators 10.1093/eurheartj/ehr333 published online Aug 28.
-
PS Sever, CL Chang, AK Gupta, A Whitehouse, NR Poulter on behalf of the ASCOT Investigators The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK Eur Heart J 2011 10.1093/eurheartj/ehr333 published online Aug 28.
-
(2011)
Eur Heart J
-
-
Sever, P.S.1
Chang, C.L.2
Gupta, A.K.3
Whitehouse, A.4
Poulter, N.R.5
-
13
-
-
83255193890
-
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: A randomised controlled trial
-
Heart Protection Study Collaborative Group 10.1016/S0140-6736(11)61125-2 published online Nov 23.
-
Heart Protection Study Collaborative Group Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial Lancet 2011 10.1016/S0140-6736(11)61125-2 published online Nov 23.
-
(2011)
Lancet
-
-
|